Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolfram H Gerlich

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Antiviral Therapy|January 7, 2015
Entecavir allows an unexpectedly high residual replication of HBV mutants resistant to lamivudineAndreas Geipel, Pia L Seiz, Hauke Niekamp, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 28, 2009
Re-evaluation of anti-HBc non-reactive serum samples from patients with persistent hepatitis B infection by immune precipitation with labelled HBV core antigenVera C Kantelhardt, Alexandra Schwarz, Ulrike Wend, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 22, 2006
Permanent loss of anti-HBc after reactivation of hepatitis B virus infection in an anti-HBs and anti-HBc-positive patient after allogeneic stem cell transplantationBarbara C Gärtner, Wolfram Jung, Christoph Welsch, et al.
Viruses|April 28, 2023
A Novel Insertion in the Hepatitis B Virus Surface Protein Leading to Hyperglycosylation Causes Diagnostic and Immune EscapeFelix Lehmann, Heiko Slanina, Martin Roderfeld, et al.
Journal of Medical Virology|January 30, 2013
Reactivation of occult hepatitis B virus infection following cytotoxic lymphoma therapy in an anti-HBc negative patientSusan A Feeney, Conall McCaughey, Alison P Watt, et al.
Gut|September 28, 2017
Quantification of large and middle proteins of hepatitis B virus surface antigen (HBsAg) as a novel tool for the identification of inactive HBV carriersMaria Pfefferkorn, Stephan Böhm, Tina Schott, et al.
Journal of Viral Hepatitis|December 6, 2025
Chronic Hepatitis B Virus Infection Acquired Under Cytostatic Treatment in Childhood - Clinical, Virological and Immunological Long-Term Follow-UpThomas Baumgarten, Felix Lehmann, Tina Senff, et al.
The New England Journal of Medicine|April 28, 2006
Variant of hepatitis B virus with primary resistance to adefovirOliver Schildgen, Hueseyin Sirma, Anneke Funk, et al.
Journal of Hepatology|September 15, 2020
Composition of HBsAg is predictive of HBsAg loss during treatment in patients with HBeAg-positive chronic hepatitis BMaria Pfefferkorn, Tina Schott, Stephan Böhm, et al.
Journal of Virology|December 28, 2007
Combination of an antiviral drug and immunomodulation against hepadnaviral infection in the woodchuck modelMengji Lu, Xin Yao, Yang Xu, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Antiviral Therapy|January 7, 2015
Entecavir allows an unexpectedly high residual replication of HBV mutants resistant to lamivudineAndreas Geipel, Pia L Seiz, Hauke Niekamp, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 28, 2009
Re-evaluation of anti-HBc non-reactive serum samples from patients with persistent hepatitis B infection by immune precipitation with labelled HBV core antigenVera C Kantelhardt, Alexandra Schwarz, Ulrike Wend, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 22, 2006
Permanent loss of anti-HBc after reactivation of hepatitis B virus infection in an anti-HBs and anti-HBc-positive patient after allogeneic stem cell transplantationBarbara C Gärtner, Wolfram Jung, Christoph Welsch, et al.
Viruses|April 28, 2023
A Novel Insertion in the Hepatitis B Virus Surface Protein Leading to Hyperglycosylation Causes Diagnostic and Immune EscapeFelix Lehmann, Heiko Slanina, Martin Roderfeld, et al.
Journal of Medical Virology|January 30, 2013
Reactivation of occult hepatitis B virus infection following cytotoxic lymphoma therapy in an anti-HBc negative patientSusan A Feeney, Conall McCaughey, Alison P Watt, et al.
Gut|September 28, 2017
Quantification of large and middle proteins of hepatitis B virus surface antigen (HBsAg) as a novel tool for the identification of inactive HBV carriersMaria Pfefferkorn, Stephan Böhm, Tina Schott, et al.
Journal of Viral Hepatitis|December 6, 2025
Chronic Hepatitis B Virus Infection Acquired Under Cytostatic Treatment in Childhood - Clinical, Virological and Immunological Long-Term Follow-UpThomas Baumgarten, Felix Lehmann, Tina Senff, et al.
The New England Journal of Medicine|April 28, 2006
Variant of hepatitis B virus with primary resistance to adefovirOliver Schildgen, Hueseyin Sirma, Anneke Funk, et al.
Journal of Hepatology|September 15, 2020
Composition of HBsAg is predictive of HBsAg loss during treatment in patients with HBeAg-positive chronic hepatitis BMaria Pfefferkorn, Tina Schott, Stephan Böhm, et al.
Journal of Virology|December 28, 2007
Combination of an antiviral drug and immunomodulation against hepadnaviral infection in the woodchuck modelMengji Lu, Xin Yao, Yang Xu, et al.
Pageof 7